Position in LH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,763,200
+$177,274 QoQ
Shares Held
13,440
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#283
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026USS Investment Management Ltd holds $156,102,736 across 12 Diagnostics & Research names. LH ranks #12 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
66,873 | $33,527,447 | |
| 2 | TWST |
Twist Bioscience Corp
|
241,224 | $24,817,125 | |
| 3 | DHR |
Danaher Corp /De/
|
114,467 | $21,803,674 | |
| 4 | VCYT |
Veracyte, Inc.
|
319,877 | $18,786,376 | |
| 5 | WAT |
Waters Corp /De/
|
26,889 | $10,084,450 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
18,668 | $9,827,581 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
48,078 | $9,289,631 | |
| 8 | A |
Agilent Technologies, Inc.
|
64,915 | $8,622,659 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,763,200 | 13,440 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,585,926 | 13,440 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,371,827 | 13,440 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,858,086 | 13,440 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,528,134 | 13,440 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,128,025 | 13,440 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,082,060 | 13,440 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,977,273 | 17,797 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,485,515 | 17,127 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||